Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity.

Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by polyglutamine expansion in the disease protein, huntingtin. In HD patients and transgenic mice, the affected neurons form characteristic ubiquitin-positive nuclear inclusions (NIs). We have established ecdysone-inducible stable mouse Neuro2a cell lines that express truncated N-terminal huntingtin (tNhtt) with different polyglutamine lengths which form both cytoplasmic and nuclear aggregates in a polyglutamine length- and inducer dose-dependent manner. Here we demonstrate that newly synthesized polyglutamine-expanded truncated huntingtin interacts with members of Hsp40 and Hsp70 families of chaperones in a polyglutamine length-dependent manner. Of these interacting chaperones, only Hdj-2 and Hsc70 frequently (Hdj-2 > Hsc70) co-localize with both the aggregates in the cellular model and with the NIs in the brains of HD exon 1 transgenic mice. However, Hdj-2 and Hsc70 do not co-localize with cytoplasmic aggregates in the brains of transgenic mice despite these chaperones being primarily localized in the cytoplasmic compartment. This strongly suggests that the chaperone interaction and their redistribution to the aggregates are two completely different phenomena of the cellular unfolded protein response. This unfolded protein response is also evident from the dramatic induction of Hsp70 on expression of polyglutamine-expanded protein in the cellular model. Transient overexpression of either Hdj-1 or Hsc70 suppresses the aggregate formation; however, suppression efficiency is much higher in Hdj-1 compared with Hsc70. Overexpression of Hdj-1 and Hsc70 is also able to protect cell death caused by polyglutamine-expanded tNhtt and their combination proved to be most effective.

[1]  Shihua Li,et al.  Cellular Defects and Altered Gene Expression in PC12 Cells Stably Expressing Mutant Huntingtin , 1999, The Journal of Neuroscience.

[2]  S. W. Davies,et al.  Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.

[3]  H. Green,et al.  Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Steven Finkbeiner,et al.  Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions , 1998, Cell.

[5]  H. Kampinga,et al.  Hsp70 and Hsp40 Chaperone Activities in the Cytoplasm and the Nucleus of Mammalian Cells* , 1997, The Journal of Biological Chemistry.

[6]  Claire-Anne Gutekunst,et al.  Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology , 1999, The Journal of Neuroscience.

[7]  S. Lindquist,et al.  Chaperone-supervised conversion of prion protein to its protease-resistant form. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Cyr,et al.  The Hdj‐2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis , 1999, The EMBO journal.

[9]  F. Hartl Molecular chaperones in cellular protein folding , 1996, Nature.

[10]  W. Chirico,et al.  Conformations of the Nucleotide and Polypeptide Binding Domains of a Cytosolic Hsp70 Molecular Chaperone Are Coupled* , 1996, The Journal of Biological Chemistry.

[11]  H. Paulson,et al.  Recruitment and the Role of Nuclear Localization in Polyglutamine-mediated Aggregation , 1998, The Journal of cell biology.

[12]  C A Ross,et al.  Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. , 1998, Human molecular genetics.

[13]  H. Paulson,et al.  Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. , 1999, Human molecular genetics.

[14]  H. Lehrach,et al.  SH3GL3 associates with the Huntingtin exon 1 protein and promotes the formation of polygln-containing protein aggregates. , 1998, Molecular cell.

[15]  M. MacDonald,et al.  Huntingtin interacts with a family of WW domain proteins. , 1998, Human molecular genetics.

[16]  C. Gross,et al.  Analysis of Three DnaK Mutant Proteins Suggests That Progression through the ATPase Cycle Requires Conformational Changes (*) , 1995, The Journal of Biological Chemistry.

[17]  Mark Turmaine,et al.  Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.

[18]  H. Paulson,et al.  Analysis of the Role of Heat Shock Protein (Hsp) Molecular Chaperones in Polyglutamine Disease , 1999, The Journal of Neuroscience.

[19]  Michael A. Mancini,et al.  Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1 , 1998, Nature Genetics.

[20]  S. W. Davies,et al.  Intranuclear Neuronal Inclusions in Huntington's Disease and Dentatorubral and Pallidoluysian Atrophy: Correlation between the Density of Inclusions andIT15CAG Triplet Repeat Length , 1998, Neurobiology of Disease.

[21]  S W Liebman,et al.  Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. , 1995, Science.

[22]  S. Sprang,et al.  Affinity panning of a library of peptides displayed on bacteriophages reveals the binding specificity of BiP , 1993, Cell.

[23]  N. Weigel,et al.  Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. , 1999, Human molecular genetics.

[24]  M. Jäättelä,et al.  Hsp70 exerts its anti‐apoptotic function downstream of caspase‐3‐like proteases , 1998, The EMBO journal.

[25]  M. Perutz,et al.  Incorporation of glutamine repeats makes protein oligomerize: implications for neurodegenerative diseases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. W. Davies,et al.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. , 1997, Science.

[27]  A. Goldberg,et al.  Involvement of the molecular chaperone Ydj1 in the ubiquitin-dependent degradation of short-lived and abnormal proteins in Saccharomyces cerevisiae , 1996, Molecular and cellular biology.

[28]  J T Finch,et al.  Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Snyder,et al.  A huntingtin-associated protein enriched in brain with implications for pathology , 1995, Nature.

[30]  Harry T Orr,et al.  Ataxin-1 Nuclear Localization and Aggregation Role in Polyglutamine-Induced Disease in SCA1 Transgenic Mice , 1998, Cell.

[31]  K. Fischbeck,et al.  Trinucleotide repeats in neurogenetic disorders. , 1996, Annual review of neuroscience.

[32]  F. Hartl,et al.  Molecular chaperone functions of heat-shock proteins. , 1993, Annual review of biochemistry.

[33]  H. Paulson,et al.  Protein fate in neurodegenerative proteinopathies: polyglutamine diseases join the (mis)fold. , 1999, American journal of human genetics.

[34]  A. Hackam,et al.  Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates , 1998, Nature Genetics.

[35]  L. Gierasch,et al.  Different conformations for the same polypeptide bound to chaperones DnaK and GroEL , 1992, Nature.

[36]  I. Kanazawa,et al.  Caspase activation during apoptotic cell death induced by expanded polyglutamine in N2a cells. , 1999, Neuroreport.

[37]  A. Goldberg,et al.  Proteasome Inhibition Leads to a Heat-shock Response, Induction of Endoplasmic Reticulum Chaperones, and Thermotolerance* , 1997, The Journal of Biological Chemistry.

[38]  K. Moulder,et al.  Generation of Neuronal Intranuclear Inclusions by Polyglutamine-GFP: Analysis of Inclusion Clearance and Toxicity as a Function of Polyglutamine Length , 1999, The Journal of Neuroscience.

[39]  F. Hartl,et al.  Molecular chaperones in cellular protein folding. , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[40]  D. Housman,et al.  The complex pathology of trinucleotide repeats. , 1997, Current opinion in cell biology.

[41]  D. Cyr,et al.  The Conserved Carboxyl Terminus and Zinc Finger-like Domain of the Co-chaperone Ydj1 Assist Hsp70 in Protein Folding* , 1998, The Journal of Biological Chemistry.

[42]  L. Bourget,et al.  Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis , 1997, Molecular and cellular biology.

[43]  C A Ross,et al.  When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases , 1995, Neuron.

[44]  A. Ciechanover,et al.  Ubiquitin-dependent Degradation of Certain Protein Substrates in Vitro Requires the Molecular Chaperone Hsc70* , 1997, The Journal of Biological Chemistry.

[45]  C A Ross,et al.  Intranuclear Neuronal Inclusions: A Common Pathogenic Mechanism for Glutamine-Repeat Neurodegenerative Diseases? , 1997, Neuron.

[46]  A. Hackam,et al.  In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease. , 1999, Human molecular genetics.

[47]  M. Gething Guidebook to the molecular chaperones and protein-folding catalysts , 1997 .

[48]  R. Tanzi,et al.  Neuronal Intranuclear Inclusions in Polyglutamine Diseases Nuclear Weapons or Nuclear Fallout? , 1998, Neuron.

[49]  H. Paulson,et al.  Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70 , 1999, Nature Genetics.